These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interstitial pneumonia associated with autoimmune diseases: a possible mimicker of SARS-CoV-2 pneumonia. Pozzi MR; Faverio P; Varisco V; D'Andrea G; Giuffrida AC; Luppi F Intern Emerg Med; 2022 Mar; 17(2):577-581. PubMed ID: 34637076 [No Abstract] [Full Text] [Related]
5. SARS-CoV-2 infection among patients with systemic autoimmune diseases. Emmi G; Bettiol A; Mattioli I; Silvestri E; Di Scala G; Urban ML; Vaglio A; Prisco D Autoimmun Rev; 2020 Jul; 19(7):102575. PubMed ID: 32376395 [TBL] [Abstract][Full Text] [Related]
6. Oral manifestations of COVID-19: Brief review. Paradowska-Stolarz AM Dent Med Probl; 2021; 58(1):123-126. PubMed ID: 33590976 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 and oral diseases: Assessing manifestations of a new pathogen in oral infections. Naqvi AR; Schwartz J; Brandini DA; Schaller S; Hussein H; Valverde A; Naqvi RA; Shukla D Int Rev Immunol; 2022; 41(4):423-437. PubMed ID: 34525891 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection as a trigger of autoimmune response. Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235 [TBL] [Abstract][Full Text] [Related]
9. Good response of low-dose steroid in a patient with COVID-19 pneumonia and autoimmune disease. Chang YY; Wang WH; Ku SW J Microbiol Immunol Infect; 2021 Oct; 54(5):1001-1002. PubMed ID: 34090821 [No Abstract] [Full Text] [Related]
10. Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report. Corchuelo J; Ulloa FC Int J Infect Dis; 2020 Nov; 100():154-157. PubMed ID: 32882435 [TBL] [Abstract][Full Text] [Related]
11. Anesthetic considerations in COVID-associated mucormycosis in a patient with autoimmune disorders. Rath A; Reena R; Jose S Minerva Anestesiol; 2022; 88(1-2):87-88. PubMed ID: 35224957 [No Abstract] [Full Text] [Related]
12. Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France. Felten R; Scherlinger M; Guffroy A; Poindron V; Meyer A; Giannini M; Korganow AS; Sordet C; Chatelus E; Javier RM; Meyer A; Pijnenburg L; Kleinmann JF; Gottenberg JE; Sibilia J; Martin T; Arnaud L Arthritis Res Ther; 2021 Jul; 23(1):188. PubMed ID: 34256812 [TBL] [Abstract][Full Text] [Related]
13. Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy. Benfaremo D; Perini L; Marconi V; Luchetti MM; Gabrielli A Eur J Intern Med; 2021 Jan; 83():90-92. PubMed ID: 33092952 [No Abstract] [Full Text] [Related]
14. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation. Darmarajan T; Paudel KR; Candasamy M; Chellian J; Madheswaran T; Sakthivel LP; Goh BH; Gupta PK; Jha NK; Devkota HP; Gupta G; Gulati M; Singh SK; Hansbro PM; Oliver BGG; Dua K; Chellappan DK Environ Sci Pollut Res Int; 2022 Aug; 29(36):54072-54087. PubMed ID: 35657545 [TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report. de Ruijter NS; Kramer G; Gons RAR; Hengstman GJD Mult Scler Relat Disord; 2020 Nov; 46():102474. PubMed ID: 32892062 [TBL] [Abstract][Full Text] [Related]
16. False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases. Kharlamova N; Dunn N; Bedri SK; Jerling S; Almgren M; Faustini F; Gunnarsson I; Rönnelid J; Pullerits R; Gjertsson I; Lundberg K; Månberg A; Pin E; Nilsson P; Hober S; Fink K; Fogdell-Hahn A Front Immunol; 2021; 12():666114. PubMed ID: 34012450 [TBL] [Abstract][Full Text] [Related]
17. Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'. Yang H; Xu J; Shi L; Duan G; Wang Y Ann Rheum Dis; 2023 Apr; 82(4):e79. PubMed ID: 33452002 [No Abstract] [Full Text] [Related]
18. Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Lee. Akiyama S; Hamdeh S; Micic D; Sakuraba A Ann Rheum Dis; 2023 Apr; 82(4):e84. PubMed ID: 33504478 [No Abstract] [Full Text] [Related]
19. The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19. Monreal E; Sainz de la Maza S; Fernández-Velasco JI; Natera-Villalba E; Rita CG; Rodríguez-Jorge F; Beltrán-Corbellini Á; Iturrieta-Zuazo I; Rodríguez de Santiago E; Espiño M; de Andrés A; Fortún J; Barbero E; Vázquez M; Fernández Lucas M; Manzano L; Montero-Errasquín B; Costa-Frossard L; Masjuan J; Villar LM; J Clin Immunol; 2021 Feb; 41(2):315-323. PubMed ID: 33236261 [TBL] [Abstract][Full Text] [Related]
20. Oral manifestations in SARS-CoV-2 infection. Tuter G; Yerebakan M; Celik B; Kara G Med Oral Patol Oral Cir Bucal; 2022 Jul; 27(4):e330-e339. PubMed ID: 35717616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]